PIMREG and colitis: A previous study has suggested that PIMREG regulates Th17 differentiation and colitis and inflammation-associated cancer by modulating transcriptional activity of STAT3, indicating that PIMREG may be correlated with immune response in the tumorigenesis (Xu C. et al., 2020).